A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration. According to EurekAlert the study found that treating diabetic macular edema (DME) with Roche’s ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone. DME is the main cause of vision loss in people with diabetes mellitus.
